Key TakeawaysZoetis raised its full-year revenue guidance by $50 million at the midpoint.The company topped second-quarter expectations on revenue but fell just short on earnings per share (EPS).Shares surged 6% in intraday trading Tuesday. Zoetis (ZTS) stock surged in intraday trading Tuesday after the company beat second-quarter revenue expectations and raised its full-year guidance. The veterinary drugmaker now expects full-year revenue of $9.1 billion to $9.25 billion, up from its prior forecast of $9.0 ...